CureMetrix, Inc.

CureMetrix is committed to the advancement of technology that will improve cancer survival rates worldwide. Our research is focused on leveraging artificial intelligence and deep learning to develop the next generation of medical image analysis technology that radiologists and patients can confidently rely on. We have surveyed radiologists globally and they have expressed the need to improve the performance of their existing Computer Aided Detection (CAD) software. At CureMetrix, we are building a ‘CAD that works.’ Today, we are honing our powerful image analysis platform into an adjunct, precision tool for mammography. Our goal is to equip radiologists with the objective, data-driven answers they need to support patients and their healthcare team as they make decisions about breast cancer screening, treatment and diagnosis. CureMetrix is committed to the advancement of technology that will improve cancer survival rates worldwide.